We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$178M
AUM Growth
-$4.03M
Cap. Flow
+$995K
Cap. Flow %
0.56%
Top 10 Hldgs %
37.36%
Holding
102
New
3
Increased
8
Reduced
41
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.01M
2
RTX icon
RTX Corp
RTX
+$730K
3
TGT icon
Target
TGT
+$338K
4
AVA icon
Avista
AVA
+$201K
5
LLY icon
Eli Lilly
LLY
+$163K

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.96%
2 Materials 13.75%
3 Healthcare 11.31%
4 Technology 9.77%
5 Real Estate 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$347B
$20.6M 11.58%
147,154
+1,236
+0.8% +$175K
STPZ icon
2
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$512M
$10.9M 6.13%
198,445
-2,740
-1% -$151K
NEM icon
3
Newmont
NEM
$95.2B
$6.8M 3.82%
125,168
+3,530
+3% +$208K
MSFT icon
4
Microsoft
MSFT
$2.99T
$5.51M 3.1%
19,546
-100
-0.5% -$29.1K
ABBV icon
5
AbbVie
ABBV
$448B
$4.43M 2.49%
41,108
-300
-0.7% -$34.3K
CEF icon
6
Sprott Physical Gold and Silver Trust
CEF
$7.3B
$4.12M 2.32%
240,773
-2,275
-0.9% -$41K
FNV icon
7
Franco-Nevada
FNV
$38.6B
$3.99M 2.24%
30,700
TGT icon
8
Target
TGT
$63.4B
$3.51M 1.98%
15,355
-1,350
-8% -$338K
MCHP icon
9
Microchip Technology
MCHP
$43.7B
$3.39M 1.91%
44,224
-1,400
-3% -$105K
CSX icon
10
CSX Corp
CSX
$93.1B
$3.18M 1.79%
106,999
-800
-0.7% -$25.6K
SH icon
11
ProShares Short S&P500
SH
$883M
$2.89M 1.63%
47,406
+22,918
+94% +$1.37M
CPRT icon
12
Copart
CPRT
$25.5B
$2.82M 1.59%
81,300
-4,400
-5% -$157K
AXP icon
13
American Express
AXP
$240B
$2.75M 1.55%
16,412
-175
-1% -$29.3K
PHYS icon
14
Sprott Physical Gold
PHYS
$14.4B
$2.7M 1.52%
195,927
MRK icon
15
Merck
MRK
$307B
$2.69M 1.51%
35,800
-300
-0.8% -$22.8K
WPM icon
16
Wheaton Precious Metals
WPM
$47B
$2.49M 1.4%
66,166
-400
-0.6% -$17.4K
PAAS icon
17
Pan American Silver
PAAS
$17.8B
$2.49M 1.4%
106,846
-240
-0.2% -$6.27K
PBTP icon
18
Invesco 0-5 Yr US TIPS ETF
PBTP
$98.9M
$2.48M 1.39%
93,400
-1,000
-1% -$26.7K
BG icon
19
Bunge Global
BG
$23.4B
$2.46M 1.39%
30,300
-200
-0.7% -$15.4K
TTE icon
20
TotalEnergies
TTE
$180B
$2.45M 1.38%
51,058
+4,900
+11% +$217K
CLX icon
21
Clorox
CLX
$11.6B
$2.39M 1.34%
14,410
-540
-4% -$93K
SPDN icon
22
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$231M
$2.36M 1.33%
150,450
-7,000
-4% -$107K
AMGN icon
23
Amgen
AMGN
$197B
$2.3M 1.29%
10,820
LLY icon
24
Eli Lilly
LLY
$1.02T
$2.29M 1.29%
9,933
-659
-6% -$163K
GRX
25
Gabelli Healthcare & Wellness Trust
GRX
$141M
$2.21M 1.24%
167,400
-1,000
-0.6% -$13.5K

Similar funds

Bennicas & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Bennicas & Associates held 102 positions worth $178M, down 2.2% from $182M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bennicas & Associates's Q3 2021 filing shows 3 new, 8 increased, 41 reduced and 3 closed positions. Its largest new stake was Petrobras: 62,300 shares worth $644K. The largest sale was Pfizer, an estimated $2.01M.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 20% a quarter earlier, followed by Materials and Healthcare.

  • Bennicas & Associates's largest Q3 2021 buy was Petrobras: 62,300 shares worth $644K.
  • Bennicas & Associates added most to ProShares Short S&P500 in Q3 2021, an estimated $1.37M increase.
  • Bennicas & Associates's biggest Q3 2021 reduction was Target, cutting an estimated $338K.
  • Bennicas & Associates fully exited Pfizer in Q3 2021, selling an estimated $2.01M.
  • Bennicas & Associates's ten largest holdings make up 37% of its $178M portfolio in Q3 2021.
  • Bennicas & Associates opened 3 new positions and closed 3 in Q3 2021.
  • Bennicas & Associates's portfolio value fell 2.2% quarter-over-quarter to $178M.

Based on Bennicas & Associates's 13F filing for Q3 2021, filed 8 Oct 2021.